Effects of ENavogliflozin on Coronary microVascular and Cardiac Function in Patients With obesitY (ENVY)
Latest Information Update: 22 Jan 2025
Price :
$35 *
At a glance
- Drugs Enavogliflozin (Primary)
- Indications Diabetes mellitus; Heart failure; Hypertension
- Focus Therapeutic Use
- Acronyms ENVY
- 22 Jan 2025 New trial record